GBp 2250.0
(-2.6%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 79.56 Million | 38.85 Million | 34.53 Million | -6.31 Million | 43.36 Million | 8.52 Million |
Net Income | 88.82 Million | 47.21 Million | 33.18 Million | 17.13 Million | 13.54 Million | 9.73 Million |
Depreciation & Amortization | 6.37 Million | 3.49 Million | 2.34 Million | 1.75 Million | 937.06 Thousand | 174.3 Thousand |
Deferred income taxes | -29.58 Million | - | -4.54 Million | -570 Thousand | -2.52 Million | -1.47 Million |
Stock-based compensation | -58 Thousand | 1.1 Million | 260 Thousand | 389 Thousand | 442.76 Thousand | 296.07 Thousand |
Change in working capital | -26.12 Million | -3.01 Million | 3.14 Million | -24.64 Million | 30.82 Million | -154.09 Thousand |
Other non-cash items | 40.13 Million | -9.5 Million | 145 Thousand | -377 Thousand | 134.32 Thousand | -39.05 Thousand |
Investing Cash Flow | -23.4 Million | -5.22 Million | -2.65 Million | -2.08 Million | -3.51 Million | -526.15 Thousand |
Investments in PPE | -15.18 Million | -5.22 Million | -2.65 Million | -2.09 Million | -3.52 Million | -526.15 Thousand |
Acquisitions | -8.22 Million | - | - | 3000.00 | 8026.00 | - |
Investment purchases | - | - | - | - | -393.63 Thousand | - |
Sales/Maturities of investments | - | - | - | - | 385.6 Thousand | - |
Other Investing Activities | -1.00 | -3.48 Million | -1.99 Million | -1.66 Million | 8026.00 | -421.26 Thousand |
Financing Cash Flow | -10.21 Million | -6.25 Million | -6.66 Million | 17.4 Million | -4.28 Million | 17.31 Million |
Debt repayment | -779 Thousand | -891 Thousand | -121 Thousand | -775 Thousand | -356 Thousand | - |
Dividends payments | -6.36 Million | -4.81 Million | -4.5 Million | - | -2.52 Million | -1.76 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 491 Thousand | 996 Thousand | 353 Thousand | 19.28 Million | 175.00 | 19.95 Million |
Other Financing Activities | -2.76 Million | -2.44 Million | -2.51 Million | -1.88 Million | -1.75 Million | -878.93 Thousand |
Accounts receivables | -1.34 Million | -1.54 Million | 127 Thousand | -1.11 Million | 236.18 Thousand | -210.61 Thousand |
Accounts payables | -15.55 Million | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -9.23 Million | -1.46 Million | 3.01 Million | -23.52 Million | 30.59 Million | 1.04 Million |
Cash at beginning of period | 141.52 Million | 108.04 Million | 82.97 Million | 73.96 Million | 38.39 Million | 13.07 Million |
Cash at end of period | 206.75 Million | 136.79 Million | 108.04 Million | 82.97 Million | 73.96 Million | 38.39 Million |
Capital Expenditure | -15.18 Million | -5.22 Million | -2.65 Million | -2.09 Million | -3.52 Million | -526.15 Thousand |
Effect of forex changes on cash | -643 Thousand | 1.38 Million | -148 Thousand | 17 Thousand | -3133.00 | 10.08 Thousand |
Net cash flow / Change in cash | 65.22 Million | 28.75 Million | 25.07 Million | 9.01 Million | 35.56 Million | 25.32 Million |
Free Cash Flow | 64.38 Million | 33.63 Million | 31.88 Million | -8.4 Million | 39.83 Million | 8 Million |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 44.84 Million | 88.82 Million | 51.22 Million | 25.61 Million | 37.6 Million | 18.8 Million |
Depreciation & Amortization | 5.41 Million | 6.37 Million | 3.8 Million | 964 Thousand | 2.58 Million | 663 Thousand |
Deferred income taxes | - | -29.58 Million | -9.1 Million | - | -4.95 Million | -464 Thousand |
Stock-based compensation | - | -58 Thousand | -271 Thousand | -271 Thousand | 242 Thousand | 242 Thousand |
Change in working capital | -25.37 Million | -26.12 Million | 15.6 Million | 11.65 Million | -21.8 Million | -9.02 Million |
Other non-cash items | 13.65 Million | 40.13 Million | 12.72 Million | -1.57 Million | 11.86 Million | -1.66 Million |
Investing Cash Flow | -4.43 Million | -23.4 Million | -16.44 Million | -5.91 Million | -6.96 Million | -3.48 Million |
Investments in PPE | -4.43 Million | -15.18 Million | -8.22 Million | -1.95 Million | -6.96 Million | -1.5 Million |
Acquisitions | 1000.00 | -8.22 Million | -8.22 Million | -4.11 Million | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -1.00 | 153.5 Thousand | 153.5 Thousand | -1.97 Million | -1.97 Million |
Financing Cash Flow | -28.13 Million | -10.21 Million | -3.31 Million | -2.98 Million | -6.9 Million | -2.12 Million |
Debt repayment | - | -779 Thousand | - | - | - | - |
Dividends payments | -5.3 Million | -6.36 Million | -1.6 Million | -801.5 Thousand | -4.76 Million | -2.38 Million |
Common Stock Repurchased | -19.84 Million | - | - | - | - | - |
Common Stock Issuance | 331 Thousand | 491 Thousand | -197 Thousand | - | 688 Thousand | - |
Other Financing Activities | -1.84 Million | -2.76 Million | -651 Thousand | -2.18 Million | -2.11 Million | 261 Thousand |
Accounts receivables | -457 Thousand | -1.34 Million | -1.78 Million | -893.5 Thousand | 444 Thousand | 222 Thousand |
Accounts payables | - | -15.55 Million | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -24.92 Million | -9.23 Million | 32.93 Million | 12.55 Million | -22.25 Million | -9.24 Million |
Cash at beginning of period | 206.75 Million | 141.52 Million | 152.2 Million | - | 141.52 Million | - |
Cash at end of period | 200.42 Million | 206.75 Million | 206.75 Million | 27.65 Million | 152.2 Million | 2.91 Million |
Capital Expenditure | -4.43 Million | -15.18 Million | -8.22 Million | -1.95 Million | -6.96 Million | -1.5 Million |
Effect of forex changes on cash | - | -643 Thousand | 170 Thousand | 170 Thousand | -491.5 Thousand | -491.5 Thousand |
Net cash flow / Change in cash | -6.32 Million | 65.22 Million | 54.54 Million | 27.65 Million | 10.68 Million | 2.91 Million |
Free Cash Flow | 22.81 Million | 64.38 Million | 65.73 Million | 34.42 Million | 18.56 Million | 7.5 Million |
MCT
8098
NORTHLINK
002239
SSVRF
MRIRF